Novel C-2 Symmetric Molecules as α-Glucosidase and α-Amylase Inhibitors: Design, Synthesis, Kinetic Evaluation, Molecular Docking and Pharmacokinetics
- Supplementary File 1:
PDF-Document (PDF, 904 KiB)
Shahzad, D.; Saeed, A.; Larik, F.A.; Channar, P.A.; Abbas, Q.; Alajmi, M.F.; Arshad, M.I.; Erben, M.F.; Hassan, M.; Raza, H.; Seo, S.-Y.; El-Seedi, H.R. Novel C-2 Symmetric Molecules as α-Glucosidase and α-Amylase Inhibitors: Design, Synthesis, Kinetic Evaluation, Molecular Docking and Pharmacokinetics. Molecules 2019, 24, 1511. https://doi.org/10.3390/molecules24081511
Shahzad D, Saeed A, Larik FA, Channar PA, Abbas Q, Alajmi MF, Arshad MI, Erben MF, Hassan M, Raza H, Seo S-Y, El-Seedi HR. Novel C-2 Symmetric Molecules as α-Glucosidase and α-Amylase Inhibitors: Design, Synthesis, Kinetic Evaluation, Molecular Docking and Pharmacokinetics. Molecules. 2019; 24(8):1511. https://doi.org/10.3390/molecules24081511
Chicago/Turabian StyleShahzad, Danish; Saeed, Aamer; Larik, Fayaz A.; Channar, Pervaiz A.; Abbas, Qamar; Alajmi, Mohamed F.; Arshad, M. I.; Erben, Mauricio F.; Hassan, Mubashir; Raza, Hussain; Seo, Sung-Yum; El-Seedi, Hesham R. 2019. "Novel C-2 Symmetric Molecules as α-Glucosidase and α-Amylase Inhibitors: Design, Synthesis, Kinetic Evaluation, Molecular Docking and Pharmacokinetics" Molecules 24, no. 8: 1511. https://doi.org/10.3390/molecules24081511